Literature DB >> 17255744

Discontinuation of secondary prophylaxis against penicilliosis marneffei in AIDS patients after HAART.

Romanee Chaiwarith1, Noppawan Charoenyos, Thira Sirisanthana, Khuanchai Supparatpinyo.   

Abstract

A retrospective cohort study was conducted to determine the relapse rate of penicilliosis marneffei after the discontinuation of itraconazole secondary prophylaxis in 33 HIV-infected patients who received HAART and had CD4 cell counts of 100 cells/mul or greater for at least 6 months. The observed incidence of relapse of penicilliosis marneffei was zero cases per 641 person-months (95% confidence interval 0-0.6 cases per person-month) after a median follow-up of 18 months (range 6-45).

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17255744     DOI： 10.1097/01.aids.0000253374.19966.f9

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


  8 in total

Review 1.  Approach to Fungal Infections in Human Immunodeficiency Virus-Infected Individuals: Pneumocystis and Beyond.

Authors:  Richard J Wang; Robert F Miller; Laurence Huang
Journal:  Clin Chest Med       Date:  2017-06-03       Impact factor: 2.878

2.  GeneXpert HIV-1 quant assay, a new tool for scale up of viral load monitoring in the success of ART programme in India.

Authors:  Smita Kulkarni; Sushama Jadhav; Priyanka Khopkar; Suvarna Sane; Rajkumar Londhe; Vaishali Chimanpure; Veronica Dhilpe; Manisha Ghate; Rajendra Yelagate; Narayan Panchal; Girish Rahane; Dilip Kadam; Nitin Gaikwad; Bharat Rewari; Raman Gangakhedkar
Journal:  BMC Infect Dis       Date:  2017-07-21       Impact factor: 3.090

3.  Penicillium marneffei Infection in AIDS.

Authors:  Stephenie Y N Wong; K F Wong
Journal:  Patholog Res Int       Date:  2011-02-10

Review 4.  Immune reconstitution inflammatory syndrome from Penicillium marneffei in an HIV-infected child: a case report and review of literature.

Authors:  Tavitiya Sudjaritruk; Thira Sirisanthana; Virat Sirisanthana
Journal:  BMC Infect Dis       Date:  2012-01-31       Impact factor: 3.090

5.  Talaromyces marneffei Infections in 8 Chinese Children with Inborn Errors of Immunity.

Authors:  Linlin Wang; Ying Luo; Xiaolin Li; Yixian Li; Yu Xia; Tingyan He; Yanyan Huang; Yongbin Xu; Zhi Yang; Jiayun Ling; Ruohang Weng; Xiaona Zhu; Zhongxiang Qi; Jun Yang
Journal:  Mycopathologia       Date:  2022-09-30       Impact factor: 3.785

6.  Paecilomyces lilacinus fungaemia in an AIDS patient: the importance of mycological diagnosis.

Authors:  Chuan Hun Ding; Mohd Nizam Tzar; Md Mostafizur Rahman; Najihan Abdul Samat Muttaqillah; Shazatul Reza Mohd Redzuan; Petrick Periyasamy
Journal:  Pak J Med Sci       Date:  2014-07       Impact factor: 1.088

7.  Clinical features of three patients with paradoxical immune reconstitution inflammatory syndrome associated with Talaromyces marneffei infection.

Authors:  Nguyen Tat Thanh; Le Duc Vinh; Nguyen Thanh Liem; Cecilia Shikuma; Jeremy N Day; Guy Thwaites; Thuy Le
Journal:  Med Mycol Case Rep       Date:  2016-12-09

8.  Is stopping secondary prophylaxis safe in HIV-positive talaromycosis patients? Experience from Myanmar.

Authors:  N Tun; A Mclean; X Deed; M Hlaing; Y Aung; E Wilkins; E Ashley; F Smithuis
Journal:  HIV Med       Date:  2020-08-01       Impact factor: 3.180
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.